Vivani Medical Participates in Investor Conferences in New York
News related to:Vivani Medical, Inc · 1 min read
ALAMEDA, Calif., Oct. 12, 2026 /CourierPR/ -- Vivani Medical, Inc., a clinical-stage biopharmaceutical company developing miniature, ultra-long-acting drug implants using its proprietary NanoPortal™ technology, is set to participate in two upcoming investor conferences in New York City this week.
On October 14, 2026, Vivani Medical will attend the Maxim Growth Summit at the Hard Rock Hotel. The company’s management team will host investor and partner meetings during this event. The following day, on October 15, 2026, Vivani will present at The ThinkEquity Conference, held at the Mandarin Oriental. Vivani’s CEO, Adam Mendelsohn, Ph.D., will deliver a presentation at this conference.
Vivani Medical’s NanoPortal™ platform is designed to develop miniature biopharmaceutical implants that deliver drug molecules steadily over extended periods, aiming to improve patient adherence and tolerance to medications. The company is currently developing a portfolio of GLP-1 based implants for metabolic diseases such as obesity and type 2 diabetes. These implants are designed for once- or twice-yearly administration, providing patients with a more convenient and effective treatment option.
According to Vivani, medication non-adherence, which occurs when patients do not take their medication as prescribed, affects approximately 50% of patients, including those taking daily pills. Vivani’s NanoPortal implants are intended to address this issue by offering a more convenient and effective treatment method.
This press release contains certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "target," "believe," "expect," "will," "may," "anticipate," "estimate," "would," "positioned," "future," and other similar expressions. These statements involve risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Vivani’s most recent Quarterly Report on Form 10-Q, filed with the SEC on August 13, 2026, as updated by future filings, provides more detailed information on the company’s financial position and plans.